Symbol Name ID |
Fas
Fas cell surface death receptor MGI:95484 |
Darker colors indicate more annotations |
Human Phenotypes | Abnormal lymphocyte apoptosis |
Decreased lymphocyte apoptosis |
Increased circulating IgA level |
Increased circulating IgE level |
Decreased circulating IgG level |
Increased circulating IgG level |
Decreased circulating total IgM |
Increased circulating IgM level |
Decreased specific anti-polysaccharide antibody level |
Increased circulating antibody level |
Reduced delayed hypersensitivity |
Abnormality of blood and blood-forming tissues |
Abnormal bleeding |
Bruising susceptibility |
Bone marrow hypercellularity |
Bone marrow hypocellularity |
Reticulocytosis |
Hemolytic anemia |
Autoimmune hemolytic anemia |
Coombs-positive hemolytic anemia |
Iron deficiency anemia |
Eosinophilia |
Neutropenia in presence of anti-neutropil antibodies |
Increased B cell count |
Decreased proportion of CD4-positive helper T cells |
Abnormal proportion of CD4-positive T cells |
Abnormal proportion of CD8-positive T cells |
Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells |
Increased proportion of HLA DR+ T cells |
Lymphocytosis |
Lymphopenia |
Leukocytosis |
Leukopenia |
Abnormal granulocyte morphology |
Abnormal basophil morphology |
Ph-positive acute lymphoblastic leukemia |
Acute myeloid leukemia |
Chronic myelogenous leukemia |
Myeloproliferative disorder |
Thrombocytopenia |
Autoimmune thrombocytopenia |
Thrombocytosis |
Hodgkin lymphoma |
Non-Hodgkin lymphoma |
B-cell lymphoma |
Burkitt lymphoma |
T-cell lymphoma |
Elevated erythrocyte sedimentation rate |
Splenomegaly |
Hepatosplenomegaly |
Hypersplenism |
Disease(s) Associated with FAS | |||||||||||||||||||||||||||||||||||||||||||||||||||
acute myeloid leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||
autoimmune lymphoproliferative syndrome | |||||||||||||||||||||||||||||||||||||||||||||||||||
chronic myeloid leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||
cystic fibrosis | |||||||||||||||||||||||||||||||||||||||||||||||||||
pre-eclampsia | |||||||||||||||||||||||||||||||||||||||||||||||||||
rheumatoid arthritis | |||||||||||||||||||||||||||||||||||||||||||||||||||
systemic lupus erythematosus |
Mouse Phenotypes | decreased B cell apoptosis |
increased T cell apoptosis |
decreased macrophage apoptosis |
impaired leukocyte tethering or rolling |
abnormal leukocyte adhesion |
abnormal T cell proliferation |
thymus cortex atrophy |
abnormal thymus medulla morphology |
increased thymus weight |
enlarged thymus |
thymus atrophy |
abnormal thymus involution |
enlarged spleen |
increased spleen weight |
abnormal B cell receptor editing |
decreased immature B cell number |
decreased transitional stage B cell number |
increased immature B cell number |
increased transitional stage B cell number |
abnormal T cell differentiation |
abnormal T cell clonal deletion |
increased double-negative T cell number |
increased double-positive T cell number |
decreased eosinophil cell number |
increased neutrophil cell number |
increased dendritic cell number |
decreased mature B cell number |
decreased marginal zone B cell number |
increased follicular B cell number |
increased marginal zone B cell number |
increased plasma cell number |
decreased B cell number |
increased B cell number |
increased NK cell number |
increased central memory CD4-positive, alpha-beta T cell number |
increased effector memory CD4-positive, alpha-beta T cell number |
decreased CD4-positive, alpha-beta T cell number |
decreased CD8-positive, alpha-beta T cell number |
increased gamma-delta T cell number |
increased memory T cell number |
decreased T cell number |
decreased activated T cell number |
increased activated T cell number |
increased lymphocyte cell number |
increased leukocyte cell number |
abnormal leukocyte morphology |
abnormal B cell morphology |
abnormal marginal zone B cell morphology |
abnormal T cell morphology |
abnormal spleen morphology |
spleen hypoplasia |
decreased spleen germinal center number |
abnormal spleen periarteriolar lymphoid sheath morphology |
abnormal splenic cell ratio |
increased splenocyte number |
abnormal B cell activation |
abnormal immunoglobulin level |
increased IgA level |
increased IgG1 level |
increased IgG2a level |
increased IgG2b level |
increased IgG3 level |
decreased IgG level |
increased IgG level |
increased IgM level |
increased immunoglobulin level |
abnormal NK cell physiology |
abnormal T cell physiology |
abnormal T-helper 2 physiology |
abnormal cytotoxic T cell physiology |
|
Availability | Mouse Genotype | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faslpr-cg/Faslpr-cg | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faslpr/Faslpr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fasm1Btlr/Fasm1Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fasm2Btlr/Fasm2Btlr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1.1Cgn/Fastm1.1Cgn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Dlo/Fastm1Dlo | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Osa/Fastm1Osa | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faslpr/Fastm1.1Cgn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Fastm1Ach/Fastm1Ach (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Ach/Fastm1Ach Tg(Lck-cre)548Jxm/? (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Ach/Fastm1Ach Tg(GZMB-cre)1Jcb/? (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Ach/Fastm1Ach Tg(Itgax-cre,-EGFP)4097Ach/? (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Cgn/Fastm1Cgn Tg(Cd4-cre)1Cwi/0 (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fastm1Cgn/Fastm1Cgn Tg(Mx1-cre)1Cgn/0 (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Faslpr/Fastm1Cgn (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cd19tm1(cre)Cgn/Cd19+ Faslpr/Fastm1Cgn Tg(Cd4-cre)1Cwi/0 (conditional) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Faslpr/Fastm1Cgn Tg(Cd4-cre)1Cwi/0 (conditional) |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|